GERMITEC, a world leader in the field of healthcare, has announced a €11 million fundraising and the appointment of its new management team, continuing its ambitious business expansion.
Winner of the Prix Galien in 2020 for the best medical device, GERMITEC has validated a solid financing plan with its new shareholders: Financière Arbevel, Sham Innovation Santé advised by Turenne Capital, Kurma Partners and funds based in Nouvelle-Aquitaine as well as private investors. This round of financing signals a strong commitment and a validation of the market potential of the technology and of the High-Level Disinfection (HLD) machines that GERMITEC has developed and is marketing.
Jérémie Swiecznik, Partner, and Benoît Courtet, Counsel, assisted the financial investors in this investment in Germitec.
Winner of the Prix Galien in 2020 for the best medical device, GERMITEC has validated a solid financing plan with its new shareholders: Financière Arbevel, Sham Innovation Santé advised by Turenne Capital, Kurma Partners and funds based in Nouvelle-Aquitaine as well as private investors. This round of financing signals a strong commitment and a validation of the market potential of the technology and of the High-Level Disinfection (HLD) machines that GERMITEC has developed and is marketing.
Jérémie Swiecznik, Partner, and Benoît Courtet, Counsel, assisted the financial investors in this investment in Germitec.